Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors - SciSparc (NASDAQ:SPRC), Clearmind Medicine (NASDAQ:CMND)
Source: benzinga.com
Stay updated with breaking news from Benzinga Psychedelics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedelics for pulmonary disorder, MS, ALS, and Parkinson's. Australian psychiatrists provide first psychedelic-assisted treatments in 50 years.